135 related articles for article (PubMed ID: 38280541)
1. Discriminatory power of a circulating multi-noncoding RNA panel in acute coronary syndrome subtypes: Towards precision detection.
Agwa SHA; Elzahwy SS; Hossam N; Yahia YA; Hamady S; Sherif N; Elshazly A; Darwish RM; Hashim JO; Adly MA; Abd Elsamee AM; Shamekh R; Roushdy MMS; Matboli M
Int J Biochem Cell Biol; 2024 Apr; 169():106531. PubMed ID: 38280541
[TBL] [Abstract][Full Text] [Related]
2. Circulating MicroRNAs in Young Patients with Acute Coronary Syndrome.
Tong KL; Mahmood Zuhdi AS; Wan Ahmad WA; Vanhoutte PM; de Magalhaes JP; Mustafa MR; Wong PF
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29762500
[TBL] [Abstract][Full Text] [Related]
3. miR-941 as a promising biomarker for acute coronary syndrome.
Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
[TBL] [Abstract][Full Text] [Related]
4. Nourin-Dependent miR-137 and miR-106b: Novel Early Inflammatory Diagnostic Biomarkers for Unstable Angina Patients.
Elgebaly SA; Christenson RH; Kandil H; El-Khazragy N; Rashed L; Yacoub B; Eldeeb H; Ali M; Sharafieh R; Klueh U; Kreutzer DL
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33670982
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miR-152-5p and miR-3681-5p function as potential biomarkers for ST-segment elevation myocardial infarction.
Chen X; Huang F; Liu Y; Liu S; Tan G
Clinics (Sao Paulo); 2022; 77():100038. PubMed ID: 35751950
[TBL] [Abstract][Full Text] [Related]
6. Novel biomarkers in the diagnosis of acute coronary syndromes: the role of circulating miRNAs.
Rognoni A; Cavallino C; Lupi A; Secco GG; Veia A; Bacchini S; Rosso R; Rametta F; Bongo AS
Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1119-24. PubMed ID: 25160996
[TBL] [Abstract][Full Text] [Related]
7. Nationwide trends in acute coronary syndrome by subtype in New Zealand 2006-2016.
Wang TKM; Grey C; Jiang Y; Jackson RT; Kerr AJ
Heart; 2020 Feb; 106(3):221-227. PubMed ID: 31672778
[TBL] [Abstract][Full Text] [Related]
8. Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction.
Bukauskas T; Mickus R; Cereskevicius D; Macas A
Med Sci Monit; 2019 May; 25():3925-3932. PubMed ID: 31130720
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka.
Ralapanawa U; Kumarasiri PVR; Jayawickreme KP; Kumarihamy P; Wijeratne Y; Ekanayake M; Dissanayake C
BMC Cardiovasc Disord; 2019 Oct; 19(1):229. PubMed ID: 31638908
[TBL] [Abstract][Full Text] [Related]
10. Elevated Levels of Circulating lncRNAs LIPCAR and MALAT1 Predict an Unfavorable Outcome in Acute Coronary Syndrome Patients.
Barbalata T; Niculescu LS; Stancu CS; Pinet F; Sima AV
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569451
[TBL] [Abstract][Full Text] [Related]
11. ABHD4-Regulating RNA Panel: Novel Biomarkers in Acute Coronary Syndrome Diagnosis.
Agwa SHA; Elzahwy SS; El Meteini MS; Elghazaly H; Saad M; Abd Elsamee AM; Shamekh R; Matboli M
Cells; 2021 Jun; 10(6):. PubMed ID: 34208452
[TBL] [Abstract][Full Text] [Related]
12. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes.
Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction.
Biener M; Giannitsis E; Thum T; Bär C; Costa A; Andrzejewski T; Stoyanov KM; Vafaie M; Meder B; Katus HA; de Gonzalo-Calvo D; Mueller-Hennessen M
Eur Heart J Acute Cardiovasc Care; 2021 Aug; 10(6):653-660. PubMed ID: 33580779
[TBL] [Abstract][Full Text] [Related]
14. [Acute coronary syndrome: diagnosis and treatment].
Stehli J; Stähli BE
Praxis (Bern 1994); 2024 Jan; 113(1):3-7. PubMed ID: 38381102
[TBL] [Abstract][Full Text] [Related]
15. High expression of lncRNA PELATON serves as a risk factor for the incidence and prognosis of acute coronary syndrome.
Chen L; Huang Y
Sci Rep; 2022 May; 12(1):8030. PubMed ID: 35577857
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement.
Mentias A; Desai MY; Saad M; Horwitz PA; Rossen JD; Panaich S; Elbadawi A; Abbott JD; Sorajja P; Jneid H; Tuzcu EM; Kapadia S; Vaughan-Sarrazin M
JACC Cardiovasc Interv; 2020 Apr; 13(8):938-950. PubMed ID: 32061612
[TBL] [Abstract][Full Text] [Related]
17. ACS encompasses a spectrum-unstable angina, NSTEMI, and STEMI.
Ibanez B; Byrne R
Eur Heart J Acute Cardiovasc Care; 2024 Feb; 13(1):187. PubMed ID: 38243612
[No Abstract] [Full Text] [Related]
18. Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome.
Li X; Yang Y; Wang L; Qiao S; Lu X; Wu Y; Xu B; Li H; Gu D
PLoS One; 2015; 10(5):e0125430. PubMed ID: 25933289
[TBL] [Abstract][Full Text] [Related]
19. [Management of acute coronary syndrome without ST-segment elevation].
Rubini Gimenez M; Thiele H; Pöss J
Herz; 2022 Aug; 47(4):381-392. PubMed ID: 35699750
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance and predictive value of D-dimer testing in patients referred to the emergency department for suspected myocardial infarction.
Koch V; Booz C; Gruenewald LD; Albrecht MH; Gruber-Rouh T; Eichler K; Yel I; Mahmoudi S; Scholtz JE; Martin SS; Graf C; Vogl TJ; Weber C; Hardt SE; Frey N; Giannitsis E
Clin Biochem; 2022 Jun; 104():22-29. PubMed ID: 35181290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
